SanegeneBio: Valuation, Funding & Investors
SanegeneBio is a privately held biotechnology company operating in the genetic and molecular biology domain, with a focus on research-stage platform technologies and services for life-science research, diagnostics, or therapeutic discovery. Publicly available, verifiable information about the company’s specific products, technology, and leadership is limited or not accessible from primary sources within the last six months.
Leadership & Board
- Current Number of Employees
- 36
- Current LinkedIn Followers
- 4,655
Latest Estimated Valuation
- Total Amount Raised
- $80M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $80M
- Latest Funding Round
- Series A
Employee Trend
SanegeneBio had 36 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
SanegeneBio had 4,655 followers as of November 2, 2026. The number of followers increased by 52 (1.13%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 01, 2024 | Series A | $80.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Tencent | Series A |
| BioVenture | Series A |
Similar Companies
A snapshot of private companies similar to SanegeneBio, helping you discover and navigate related company profiles.
